Companion Diagnostics and Biomarker Development
Biosimilars: Pipeline Trends
Datamonitor has identified a total of 397 biosimilars/copy-biologics across 125 companies as being in development/marked. Products and pipeline candidates were identified using publically available information (where available). For each candidate, the stage of development was determined using […]
Phase IV Clinical Trials: Best Practices in Post-Marketing Study Management
Moving Toward Health Outcome Liaisons: A Comparison of MSL and HOL Compensation Reflects an Industry Shift
Health Outcomes Liaisons: Managing a Field-Based Team that Speaks the Payer’s Language
Generic Pharmaceuticals Market – A Global Analysis
The research report aims to analyze and assess the global generics pharmaceutical market, map the key trends and dynamics shaping the industry sector and provide strategic recommendations for the success of the market participants. With several key blockbuster drugs losing patent protection and new […]
U.S. Managed Markets: Driving Commercial Success through Outcomes-Based Reimbursement
The State of the EDC and ePRO Market
Win US Reimbursement and Build Payer Relationships
2010 Biosimilar Prescribing Outlook
This study - designed, executed and analyzed by research professionals from the drug development and commercialization industry - sheds light on prescribers' views of biosimilars. It is based on interviews with 264 physicians in the United States and Western Europe. […]
2011 CRO Quality Benchmarking Report
Pharmaceutical Pricing Strategy
Biosimilars Regulatory Update: an evolving landscape
Autoimmune Market Forecast to 2014
2010 CRO Quality Benchmarking Report
Market Access Management
Biosimilars: Surveying the Market Landscape
Diabetes Market Forecast to 2015
Healthcare Market Access Management: Building Teams that Deliver Value to Payers
2012 Rheumatology Reimbursement Report
Survey Results Identify Key Trends Related to Oral Meds, RA Management, Cost of Therapy, and More […]
Securing Market Access Medical Affairs
Oncology Market Forecast to 2015
Risk Sharing and Innovative Contracting with CROs
Pharmaceutical Pricing Strategy: Maximize Revenue in an Evolving Economic Climate
Strategic Pharmaceutical Competitive Intelligence Improve Market Research Impact
Health Outcomes Liaisons: Managing a Field-Based Team That Speaks the Payer’s Language
2012 Medicines in Development for Cancer report
PhRMA’s 2012 Medicines in Development for Cancer report includes information on new oncology drugs in the pipeline and their current development status. The report is broken down by type of cancer and is followed by additional fact sheets and other helpful resources. Our goal is that the report not […]
Health Economics and Outcomes Research
Opportunities in Emerging Markets-Developing Asia
